Context Therapeutics Inc. (CNTX:NASDAQ) closed at $0.240 on October 26, 2026, up 0.25% on the day. The stock trades 93.4% below its 52-week high of $3.62 and 11.6% above its 52-week low of $0.215. Over the past year, it lost 80.5%. Context Therapeutics Inc. is part of the Health Care sector.
In 252 trading sessions since October 24, 2025, CNTX closed higher on 117 days (46%). Its best day was January 26, 2026 (+14.92%) and its worst was June 15, 2026 (-51.15%). The stock moved 10% or more in a single session 14 times. It opened at least 5% above the previous day's high 2 times.
Centrexion Therapeutics Corp is a late clinical-stage biopharmaceutical company. It is mainly engaged in identifying, developing and commercializing novel, non-opioid, non-addictive therapies to address the unmet medical need for the treatment of chronic pain. Its product candidate, CNTX-4975, is designed to selectively and locally target and disrupt the signaling of pain-sensing nerve fibers. Its other product candidate includes CNTX-0290, CNTX-6970, CNTX-2022, and CNTX-6016.
Find more stocks like CNTX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.